Skip to content

Effect of Aromatherapy with Rose extract in controlling postoperative pain

Study effect of Aromatherapy with Rose extract in controlling postoperative pain in inguinal hernia operation

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201703139597N3
Enrollment
80
Registered
2017-11-19
Start date
2017-11-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pain localized to other parts of lower abdomen. Condition 2: Inguinal hernia. Pain localized to other parts of lower abdomen Inguinal hernia

Interventions

Intervention 1: In the intervention group, 4 drops of rose extract of 4% were made by Barij Essence, 15 minutes prior to the end of inguinal hernia operation, and through the nares ( 2 drops in each n
Treatment - Other
Placebo
In the intervention group, 4 drops of rose extract of 4% were made by Barij Essence, 15 minutes prior to the end of inguinal hernia operation, and through the nares ( 2 drops in each nostril).
In the control group, 4 drops of distilled water, 15 minutes prior to the end of inguinal hernia operation, and through the nares ( 2 drops in each nostril).

Sponsors

Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a)Age of 20-50 years; (b) Patients with class 1 or 2 according to the American Society of Anesthesiology scoring criteria; (c) No history of opium and psychotropic drugs; (d) No Long-term used anti inflammatory non-opoid; (e)No systemic disease; (f)Not sensitive to used drugs ; (g)Woman is not pregnant. Exclusion criteria: (a) Lack of access to the patient for measuring pain; (b)the patient's inability to determine the pain score for any reason; (c) Morbidity sensitivity to the Rose extraction in the intervention group.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: 1, 6, 12, , and 24 hours after surgery. Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Side effects of drugs. Timepoint: 1, 6, 12 and 24 hours after surgery. Method of measurement: questionnaire.;Hemodynamic status. Timepoint: 1, 6, 12 and 24 hours after surgery. Method of measurement: Esphigmomanometery and pulse oximetry.;Analgesic dosage used. Timepoint: 1, 6, 12 and 24 hours after surgery. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohammad Zolhavarieh

Hamadan University of Medical Sciences

dsmbszolhavarieh@gmail.com+98 81 3838 0749

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026